OTSUKA | Sustainability Performance
Healthcare company with businesses in pharmaceuticals, nutraceuticals, and consumer products.
2008
Japan
10,001+ employees
Pharmaceuticals
$1B - 10B in revenue
$100M - 500M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#1327
Overallⓘ#84
in Japanⓘ#40
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Carbon emissionsEnergy consumptionWaste ManagementWater ManagementNature and biodiversitySocial
Diversity and InclusionPay GapsHealth and SafetyExternalitiesGovernance
SDG ImpactFinancial Data
Business performanceCapital & innovationAnalyst projections
Leading
Critical
Aligned
Laggard
Critical
Intensity
Greenhouse gas intensity (Scope 1, 2, 3)(tCO₂e /$M)
Energy consumption (direct) intensity (MWh /$M)
Waste generation intensity (tonnes /$M)
Industry Benchmark
369.9
B/M 312.2
9.6
B/M 42.0
1.5
B/M 0.4
Powered by illuminem and GIST Impact
Controversy level
- Otsuka Holdings Co Ltd, Japanese pharma/Pocari Sweat/Calorie Mate, has faced multiple US FDA Form 483 observations at multiple production facilities including the contested historic Abilify (aripiprazole) compulsive behavior class actions, plus periodic Japanese FSA enforcement scrutiny on inadequate disclosure of US Otsuka America customer concentration affecting Japanese institutional shareholders.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
2-3
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.